Hi all,
Just saw this!


Published online 22 April 2009 | Nature 458, 950-951 (2009) | doi:10.1038/458950b

News
Pharmaceutical companies join forces on HIV

GlaxoSmithKline and Pfizer create spin-off to develop new combination drugs.


GlaxoSmithKline (GSK) and Pfizer plan to merge their HIV drug divisions in an unusual move designed to shore up their poor market positions. The marriage will create a new company, yet to be named, which will use the existing research and market portfolios of the parent companies to develop new combination drugs, the mainstay of HIV treatment.

T

This kind of collaboration is what was discussed here a few weeks ago...........I would like to think that Big Pharma guys are reading neurotalk.....Probably not!!!

Its interesting to see how big pharma works! In any case, it is a good thing to see companies pooling their money and effort to focus on developing drugs.
girija